Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization, natural biodistribution, and acute toxicity.
The clinical outcome of patients with ischemic heart disease can be significantly improved with the implementation of targeted drug delivery into the ischemic myocardium. In this paper, we present our original findings relevant to the problem of therapeutic heart targeting with use of nanoparticles. Experimental approaches included fabrication of carbon and silica nanoparticles, their characterization and surface modification. The acute hemodynamic effects of nanoparticle formulation as well as nanoparticle biodistribution were studied in male Wistar rats. Carbon and silica nanoparticles are nontoxic materials that can be used as carriers for heart-targeted drug delivery. Concepts of passive and active targeting can be applied to the development of targeted drug delivery to the ischemic myocardial cells. Provided that ischemic heart-targeted drug delivery can be proved to be safe and efficient, the results of this research may contribute to the development of new technologies in the pharmaceutical industry.
Galagudza
Michael M
MM
Institute of Experimental Medicine, VA. Almazov Federal Heart, Blood and Endocrinology Center, St-Petersburg, Russian Federation. galagoudza@mail.ru
Korolev
Dmitry V
DV
Sonin
Dmitry L
DL
Postnov
Viktor N
VN
Papayan
Garry V
GV
Uskov
Ivan S
IS
Belozertseva
Anastasia V
AV
Shlyakhto
Eugene V
EV
D000818:Animals; D002316:Cardiotonic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics*; D004337:Drug Carriers / Q000008:administration & dosage* / Q000138:chemical synthesis / Q000493:pharmacokinetics; D008297:Male; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000378:metabolism*; D053758:Nanoparticles / Q000008:administration & dosage* / Q000737:chemistry; D009928:Organ Specificity; D051381:Rats; D017208:Rats, Wistar; D012822:Silicon Dioxide / Q000737:chemistry*; D014018:Tissue Distribution; D016896:Treatment Outcome
D002316:Cardiotonic Agents; D004337:Drug Carriers; D012822:Silicon Dioxide
ACS Nano. 2009 Oct 27;3(10):3273-86
19739605
Prog Lipid Res. 2005 Jul;44(4):207-34
15979148
Adv Drug Deliv Rev. 2008 Aug 17;60(11):1278-88
18514969
J Am Chem Soc. 2009 Jun 24;131(24):8398-400
19476380
Cancer Res. 1986 Dec;46(12 Pt 1):6387-92
2946403
Chem Commun (Camb). 2009 Jun 14;(22):3219-21
19587919
J Am Coll Cardiol. 2009 Feb 24;53(8):709-17
19232905
Cardiovasc Hematol Disord Drug Targets. 2009 Sep;9(3):206-21
19817715
Nano Lett. 2009 Sep;9(9):3308-11
19736973